Loading...
XNYS
ASH
Market cap2.98bUSD
Jul 09, Last price  
65.00USD
1D
2.04%
1Q
15.21%
Jan 2017
-40.53%
Name

Ashland Inc

Chart & Performance

D1W1MN
XNYS:ASH chart
P/E
P/S
1.63
EPS
Div Yield, %
2.54%
Shrs. gr., 5y
-5.49%
Rev. gr., 5y
-1.98%
Revenues
1.82b
-13.68%
7,233,000,0007,785,000,0008,381,000,0008,106,000,0005,741,000,0006,502,000,0006,472,000,0006,091,000,0006,121,000,0003,420,000,0003,019,000,0002,309,000,0002,589,000,0002,148,000,0002,016,000,0002,111,000,0002,391,000,0002,191,000,0002,113,000,0001,824,000,000
Net income
-845m
L
407,000,000230,000,000167,000,00071,000,000141,000,000414,000,00026,000,000683,000,000233,000,000309,000,000-29,000,0001,000,000114,000,000505,000,000-508,000,000220,000,000927,000,000178,000,000169,000,000-845,000,000
CFO
94m
-77.13%
345,000,000195,000,000470,000,0001,025,000,000507,000,000245,000,000354,000,000733,000,000643,000,000333,000,000678,000,000383,000,000297,000,000241,000,000203,000,000560,000,000-213,000,000243,000,000411,000,00094,000,000
Dividend
Dec 01, 20250.415 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
IPO date
Mar 17, 1980
Employees
3,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT